These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7648647)

  • 41. Withdrawal of nifedipine capsules: jeopardising the treatment of acute severe hypertension in pregnancy?
    Langton PE
    Med J Aust; 1998 Jan; 168(1):43-4. PubMed ID: 9451398
    [No Abstract]   [Full Text] [Related]  

  • 42. The haemodynamic effects of nifedipine, verapamil and diltiazem in patients with coronary artery disease. A review.
    Soward AL; Vanhaleweyk GL; Serruys PW
    Drugs; 1986 Jul; 32(1):66-101. PubMed ID: 2874975
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative effects of two slow channel calcium entry blockers, FR 34235 and nifedipine, on true coronary collateral blood flow.
    Gross GJ; Warltier DC; Hardman HF
    J Cardiovasc Pharmacol; 1984; 6(1):61-7. PubMed ID: 6199613
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Calcium ion blocking drugs.
    Resnekov L
    Compr Ther; 1982 Jul; 8(7):10-5. PubMed ID: 7116804
    [No Abstract]   [Full Text] [Related]  

  • 45. Nifedipine for angina and acute myocardial ischaemia.
    Hugenholtz PG; Verdouw PD; de Jong JW; Serruys PW
    Postgrad Med J; 1983; 59 Suppl 2():40-58. PubMed ID: 6351043
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The use of sublingual nifedipine: a continuing concern.
    Messerli FH; Grossman E
    Arch Intern Med; 1999 Oct; 159(19):2259-60. PubMed ID: 10547164
    [No Abstract]   [Full Text] [Related]  

  • 47. [Bioequivalence of nifedipine sustained-release formulations in comparison to standard preparations in solid state].
    Herrmann R
    Arzneimittelforschung; 1996 Jan; 46(1):28-34. PubMed ID: 8821514
    [TBL] [Abstract][Full Text] [Related]  

  • 48. FDA gives calcium channel blockers clean bill of health but warns of short-acting nifedipine hazards.
    Marwick C
    JAMA; 1996 Feb; 275(6):423-4. PubMed ID: 8627948
    [No Abstract]   [Full Text] [Related]  

  • 49. Nifedipine gastrointestinal therapeutic system versus nifedipine coat-core: comparison of efficacy via 24-hour ambulatory blood pressure monitoring.
    Defina LF; Bookstaver DA; Goldfinger MP; Coffey TA
    Ann Pharmacother; 1997; 31(7-8):819-22. PubMed ID: 9220037
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential effects of two dihydropyridine calcium antagonists in humans.
    Belz GG; Bliesath H; Essig J; Neumann N; Zech K; Wurst W
    Clin Pharmacol Ther; 1992 Jul; 52(1):68-79. PubMed ID: 1623694
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Calcium antagonists--much noise about nothing?].
    Oberpichler-Schwenk H
    Med Monatsschr Pharm; 1995 Dec; 18(12):344-9. PubMed ID: 8569586
    [No Abstract]   [Full Text] [Related]  

  • 52. Risks and benefits of calcium antagonists.
    Opie LH
    Lancet; 1995 Oct; 346(8980):961. PubMed ID: 7564738
    [No Abstract]   [Full Text] [Related]  

  • 53. FDA committee recommends stronger warnings against inappropriate use of immediate-release nifedipine.
    Miller JL
    Am J Health Syst Pharm; 1996 Mar; 53(6):599-600. PubMed ID: 8800958
    [No Abstract]   [Full Text] [Related]  

  • 54. [Protective effect of nicardipine hydrochloride on the perfused ischemic canine myocardium].
    Sunamori M; Okamura T; Amano J; Suzuki A
    Kokyu To Junkan; 1983 Nov; 31(11):1241-4. PubMed ID: 6676796
    [No Abstract]   [Full Text] [Related]  

  • 55. Effect of nifedipine and niludipine on myocardial pH in the ischemic canine heart.
    Ichihara K; Sakai K; Abiko Y
    Arch Int Pharmacodyn Ther; 1986 Mar; 280(1):58-73. PubMed ID: 3718082
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nifedipine-induced gingival overgrowth.
    Johnson RB
    Ann Pharmacother; 1997; 31(7-8):935. PubMed ID: 9220065
    [No Abstract]   [Full Text] [Related]  

  • 57. Nifedipine preparations on the Belgian market: a comparative study.
    De Braekeleer K; Fierens C; Corthout J
    J Pharm Belg; 2009 Dec; (4):141-6. PubMed ID: 20183991
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Chemotherapy in ischemic heart disease. Experience with Nifedipine (Corinfar)].
    Schwela H; Oltmanns G; Assmann I; Barthels U; Fiehring H
    Z Gesamte Inn Med; 1977 Oct; 32(19):479-83. PubMed ID: 339576
    [No Abstract]   [Full Text] [Related]  

  • 59. Critical appraisal of recent studies on nifedipine and other calcium channel blockers in coronary artery disease and hypertension.
    Tijssen JG; Hugenholtz PG
    Eur Heart J; 1996 Aug; 17(8):1152-7. PubMed ID: 8869855
    [No Abstract]   [Full Text] [Related]  

  • 60. Combined therapy with beta-adrenergic blockers and calcium-antagonists in patients with ischemic heart disease.
    Winniford MD; Hillis LD
    Herz; 1982 Aug; 7(4):243-9. PubMed ID: 6127300
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.